Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Nanotechnology|January 9, 2014
Integrated multiplatform method for in vitro quantitative assessment of cellular uptake for fluorescent polymer nanoparticlesRaffaele Ferrari, Monica Lupi, Francesca Falcetta, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2011
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancerGiuseppina Della Vittoria Scarpati, Francesca Falcetta, Chiara Carlomagno, et al.
Clinical Pharmacology and Therapeutics|October 13, 2017
Application of 3D Mass Spectrometry Imaging to TKIsLavinia Morosi, Silvia Giordano, Francesca Falcetta, et al.
Molecular Pharmaceutics|December 2, 2015
PEGylated Nanoparticles Obtained through Emulsion Polymerization as Paclitaxel CarriersClaudio Colombo, Lavinia Morosi, Ezia Bello, et al.
Cancers|October 21, 2020
Retinoic Acid Sensitivity of Triple-Negative Breast Cancer Cells Characterized by Constitutive Activation of the notch1 Pathway: The Role of RarβGabriela Paroni, Adriana Zanetti, Maria Monica Barzago, et al.
International Journal of Cancer|May 13, 2018
Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumabFrancesca Bizzaro, Francesca Falcetta, Elisa D'Agostini, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 14, 2021
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signalingMarco Giordano, Alessandra Decio, Chiara Battistini, et al.
Biomacromolecules|January 22, 2016
Fate of PLA and PCL-Based Polymeric Nanocarriers in Cellular and Animal Models of Triple-Negative Breast CancerLeopoldo Sitia, Raffaele Ferrari, Martina B Violatto, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 11, 2021
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical modelsLavinia Morosi, Marina Meroni, Paolo Ubezio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid LiposarcomasRoberta Frapolli, Ezia Bello, Marianna Ponzo, et al.
Pageof 6